Ethos Financial Group »

Nrx Pharmaceuticals shares owned by Ethos Financial Group

Quarter-by-quarter ownership of Nrx Pharmaceuticals (NRXP) shares owned by Ethos Financial Group from 13F filings

Historical chart of Ethos Financial Group investment in Nrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Nrx Pharmaceuticals held by Ethos Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nrx Pharmaceuticals by Ethos Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $39k 12k 3.30

More positions owned by Ethos Financial Group

Schwab U.S. Broad Market Etf Etf (SCHB)
Vanguard S&P 500 Etf Etf (VOO)
Relative Sentiment Tactical Allocation Etf Etf (MOOD)
Abrdn Physical Gold Shares Etf Etf (SGOL)
Alpha Architect 13 Month Box Etf Etf (BOXX)
Schwab Us Large Cap Etf Etf (SCHX)
Vanguard Total World Stock Etf Etf (VT)
Schwab Us Large Cap Growth Etf Etf (SCHG)
Vaneck Morningstar Wide Moat Etf Etf (MOAT)
Spdr S&P 500 Etf Etf (SPY)
Invsc S P 500 Momentum Etf Etf (SPMO)
Schwab Us Large Cap Value Etf Etf (SCHV)
Ishares Tips Bond Etf Etf (TIP)
Ishares Russell 1000 Growth Etf Etf (IWF)
Select Sector Spdr Tr Etf (XLU)

View all positions for Ethos Financial Group

Top funds holding Nrx Pharmaceuticals

Frigate Ventures
Vanguard Group
AdvisorShares Investments
Marshall Wace
Geode Capital Management
UBS Group
Renaissance Technologies
Jane Street
State Street Corporation
BlackRock
Two Sigma Investments
Chicago Partners Investment
Susquehanna International
Citadel Advisors
Northern Trust

View all funds holding Nrx Pharmaceuticals